These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

464 related items for PubMed ID: 12716522

  • 61.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 62. Assessing routine and serum markers of liver fibrosis in CHB patients using parallel and serial interpretation.
    Hongbo L, Xiaohui L, Hong K, Wei W, Yong Z.
    Clin Biochem; 2007 May; 40(8):562-6. PubMed ID: 17362902
    [Abstract] [Full Text] [Related]

  • 63. Cirrhosis in hepatitis C virus-infected patients can be excluded using an index of standard biochemical serum markers.
    Islam S, Antonsson L, Westin J, Lagging M.
    Scand J Gastroenterol; 2005 Jul; 40(7):867-72. PubMed ID: 16109665
    [Abstract] [Full Text] [Related]

  • 64. Serum surrogate markers of liver fibrosis in primary biliary cirrhosis.
    Voumvouraki A, Koulentaki M, Notas G, Sfakianaki O, Kouroumalis E.
    Eur J Intern Med; 2011 Feb; 22(1):77-83. PubMed ID: 21238899
    [Abstract] [Full Text] [Related]

  • 65. Serum markers of liver fibrosis and histologic severity of fibrosis in resected liver.
    Tsukamoto T, Yamamoto T, Ikebe T, Takemura S, Shuto T, Kubo S, Hirohashi K, Kinoshita H.
    Hepatogastroenterology; 2004 Feb; 51(57):777-80. PubMed ID: 15143915
    [Abstract] [Full Text] [Related]

  • 66. Altered serum N-glycomics in chronic hepatitis B patients.
    Gui HL, Gao CF, Wang H, Liu XE, Xie Q, Dewaele S, Wang L, Zhuang H, Contreras R, Libert C, Chen C.
    Liver Int; 2010 Feb; 30(2):259-67. PubMed ID: 19951379
    [Abstract] [Full Text] [Related]

  • 67. [The value of serum retinol-binding protein 4 levels for determining disease severity in patients with chronic liver disease].
    Kwon JH, Park ST, Kim GD, You CR, Kim JD, Woo HY, Jang JW, Kim CW, Bae SH, Choi JY, Yoon SK.
    Korean J Hepatol; 2009 Mar; 15(1):59-69. PubMed ID: 19346786
    [Abstract] [Full Text] [Related]

  • 68. Hyaluronic acid and aspartate aminotransferase levels normalized by liver function can reflect sinusoidal impairment in chronic liver disease.
    Testa E, Malfatti F, Milazzo S, Cordiviola C, Cotellessa T, Marabotto E, Giannini E, Ceppa P, Mamone M, Risso D, Testa R.
    Liver Int; 2006 May; 26(4):439-44. PubMed ID: 16629647
    [Abstract] [Full Text] [Related]

  • 69. Comprehensive clinical assessment improves the accuracy of predicting cirrhosis in chronic hepatitis C.
    Gordon A, Bailey MJ, Gibson PR, Roberts SK.
    J Gastroenterol Hepatol; 2005 Jun; 20(6):825-32. PubMed ID: 15946128
    [Abstract] [Full Text] [Related]

  • 70. Serological markers for monitoring disease progression in noncirrhotic primary biliary cirrhosis on ursodeoxycholic acid therapy.
    Färkkilä M, Rautiainen H, Kärkkäinen P, Karvonen AL, Nurmi H, Niemelä O.
    Liver Int; 2008 Jul; 28(6):787-97. PubMed ID: 18397236
    [Abstract] [Full Text] [Related]

  • 71. Usefulness of serum hepatic fibrosis markers in the diagnosis of nonalcoholic steatohepatitis (NASH).
    Sasaki N, Ueno T, Morita Y, Nagata E, Sata M.
    Hepatogastroenterology; 2006 Jul; 53(71):678-81. PubMed ID: 17086867
    [Abstract] [Full Text] [Related]

  • 72.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 73. Role of hyaluronic acid and laminin as serum markers for predicting significant fibrosis in patients with chronic hepatitis B.
    Li F, Zhu CL, Zhang H, Huang H, Wei Q, Zhu X, Cheng XY.
    Braz J Infect Dis; 2012 Jul; 16(1):9-14. PubMed ID: 22358349
    [Abstract] [Full Text] [Related]

  • 74. [Relationship between serum HBV DNA levels and serum hyaluronic acid levels in hepatitis B cirrhosis patients].
    Li HY, Dong Z, Ma H.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Sep; 21(3):256-7. PubMed ID: 17971938
    [Abstract] [Full Text] [Related]

  • 75. [Noninvasive assessment of liver fibrosis in chronic hepatitis B using a predictive model].
    Zhang WS, Wang BE, Wang TL, Ou XJ, Chen Y, Li Q, Wang XM, Qian LX, Ma H, Jia JD.
    Zhonghua Gan Zang Bing Za Zhi; 2006 Mar; 14(3):169-73. PubMed ID: 16556408
    [Abstract] [Full Text] [Related]

  • 76. Determination of serum fibrosis index in patients with chronic hepatitis and its relationship to histological activity index.
    Elmetwally IM, Elmahalaway AM, Abuhashem SH, Ahmed AM.
    Saudi Med J; 2009 May; 30(5):638-46. PubMed ID: 19417962
    [Abstract] [Full Text] [Related]

  • 77. [Relationship between serum fibrosis markers and fibrosis quantitative analysis of liver tissue].
    Gu S, Zhang H, Zhang L.
    Zhonghua Gan Zang Bing Za Zhi; 1999 Dec; 7(4):199-200. PubMed ID: 10715785
    [Abstract] [Full Text] [Related]

  • 78. [The diagnostic value of eight serum indices for liver fibrosis].
    Cai WM, Zhang BB, Weng HL, Hu ZR, Lv J, Zheng M, Liu RH.
    Zhonghua Gan Zang Bing Za Zhi; 2004 Apr; 12(4):219-22. PubMed ID: 15099471
    [Abstract] [Full Text] [Related]

  • 79. Assessment of graft fibrosis by transient elastography in patients with recurrent hepatitis C after living donor liver transplantation.
    Harada N, Soejima Y, Taketomi A, Yoshizumi T, Ikegami T, Yamashita Y, Itoh S, Kuroda Y, Maehara Y.
    Transplantation; 2008 Jan 15; 85(1):69-74. PubMed ID: 18192914
    [Abstract] [Full Text] [Related]

  • 80. [Clinical significance of serum fibrosis markers in diagnosis of infantile hepatitis syndrome].
    Deng WL, Xiong H, Wang LL, Zou XB.
    Zhongguo Dang Dai Er Ke Za Zhi; 2014 Oct 15; 16(10):1029-32. PubMed ID: 25344185
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 24.